Consistent antioxidant and antihypertensive effects of oral sodium nitrite in DOCA-salt hypertension

Gladwin, 2005, The emerging biology of the nitrite anion, Nat. Chem. Biol., 1, 308, 10.1038/nchembio1105-308 Kapil, 2010, Inorganic nitrate and the cardiovascular system, Heart, 96, 1703, 10.1136/hrt.2009.180372 Lundberg, 2009, Nitrate and nitrite in biology, nutrition and therapeutics, Nat. Chem. Biol., 5, 865, 10.1038/nchembio.260 McKnight, 1997, Chemical synthesis of nitric oxide in the stomach from dietary nitrate in humans, Gut, 40, 211, 10.1136/gut.40.2.211 Amaral, 2013, Tempol enhances the antihypertensive effects of sodium nitrite by mechanisms facilitating nitrite-derived gastric nitric oxide formation, Free Radic. Biol. Med., 65, 446, 10.1016/j.freeradbiomed.2013.07.032 Pinheiro, 2012, Increase in gastric pH reduces hypotensive effect of oral sodium nitrite in rats, Free Radic. Biol. Med., 53, 701, 10.1016/j.freeradbiomed.2012.06.001 Cosby, 2003, Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation, Nat. Med., 9, 1498, 10.1038/nm954 Shiva, 2007, Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration, Circ. Res., 100, 654, 10.1161/01.RES.0000260171.52224.6b Webb, 2004, Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage, Proc. Natl. Acad. Sci. U. S. A., 101, 13683, 10.1073/pnas.0402927101 Li, 2008, Nitric oxide production from nitrite occurs primarily in tissues not in the blood: critical role of xanthine oxidase and aldehyde oxidase, J. Biol. Chem., 283, 17855, 10.1074/jbc.M801785200 Montenegro, 2014, Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension, Naunyn Schmiedebergs Arch. Pharmacol., 387, 591, 10.1007/s00210-014-0970-8 Gautier, 2006, Endothelial nitric oxide synthase reduces nitrite anions to NO under anoxia, Biochem. Biophys. Res. Commun., 341, 816, 10.1016/j.bbrc.2006.01.031 Kozlov, 1999, Nitrite reductase activity is a novel function of mammalian mitochondria, FEBS Lett., 454, 127, 10.1016/S0014-5793(99)00788-7 Bryan, 2005, Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues, Nat. Chem. Biol., 1, 290, 10.1038/nchembio734 Montenegro, 2011, Sodium nitrite downregulates vascular NADPH oxidase and exerts antihypertensive effects in hypertension, Free Radic. Biol. Med., 51, 144, 10.1016/j.freeradbiomed.2011.04.005 Gao, 2015, NADPH oxidase in the renal microvasculature is a primary target for blood pressure-lowering effects by inorganic nitrate and nitrite, Hypertension, 65, 161, 10.1161/HYPERTENSIONAHA.114.04222 de Champlain, 2004, Oxidative stress in hypertension, Clin. Exp. Hypertens., 26, 593, 10.1081/CEH-200031904 Gomes, 2013, Assessment of oxidative status markers and NO bioavailability in hypertensive disorders of pregnancy, J. Hum. Hypertens., 27, 345, 10.1038/jhh.2012.58 Sandrim, 2010, Increased circulating cell-free hemoglobin levels reduce nitric oxide bioavailability in preeclampsia, Free Radic. Biol. Med., 49, 493, 10.1016/j.freeradbiomed.2010.05.012 Montenegro, 2012, Antihypertensive and antioxidant effects of a single daily dose of sodium nitrite in a model of renovascular hypertension, Naunyn Schmiedebergs Arch. Pharmacol., 385, 509, 10.1007/s00210-011-0712-0 Pinheiro, 2014, The antihypertensive effects of sodium nitrite are not associated with circulating angiotensin converting enzyme inhibition, Nitric Oxide, 40, 52, 10.1016/j.niox.2014.05.009 Ghosh, 2013, Enhanced vasodilator activity of nitrite in hypertension: critical role for erythrocytic xanthine oxidoreductase and translational potential, Hypertension, 61, 1091, 10.1161/HYPERTENSIONAHA.111.00933 Carlström, 2014, Cross-talk between nitrate–Nitrite–NO and NO synthase pathways in control of vascular NO homeostasis, Antioxid. Redox Signal. Carlström, 2011, Dietary nitrate attenuates oxidative stress, prevents cardiac and renal injuries, and reduces blood pressure in salt-induced hypertension, Cardiovasc. Res., 89, 574, 10.1093/cvr/cvq366 Chen, 2013, Anti-stiffness effect of apocynin in deoxycorticosterone acetate-salt hypertensive rats via inhibition of oxidative stress, Hypertens. Res., 36, 306, 10.1038/hr.2012.170 Sarikonda, 2009, Experimental animal models of hypertension, J. Am. Soc. Hypertens., 3, 158, 10.1016/j.jash.2009.02.003 Fujii, 2006, Role of gp91phox-containing NADPH oxidase in the deoxycorticosterone acetate-salt-induced hypertension, Eur. J. Pharmacol., 552, 131, 10.1016/j.ejphar.2006.09.039 Martins-Oliveira, 2013, Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling, Int. J. Cardiol., 167, 1199, 10.1016/j.ijcard.2012.03.137 Ceron, 2012, Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension, Matrix Biol. J. Int. Soc. Matrix Biol., 31, 261, 10.1016/j.matbio.2012.01.009 Gómez-Guzmán, 2012, Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension, Free Radic. Biol. Med., 52, 70, 10.1016/j.freeradbiomed.2011.09.015 Singh, 2012, Dietary nitrite attenuates oxidative stress and activates antioxidant genes in rat heart during hypobaric hypoxia, Nitric Oxide, 26, 61, 10.1016/j.niox.2011.12.002 Dias-Junior, 2006, Low-dose intravenous nitrite improves hemodynamics in a canine model of acute pulmonary thromboembolism, Free Radic. Biol. Med., 41, 1764, 10.1016/j.freeradbiomed.2006.08.022 Montenegro, 2009, Assessment of vascular effects of tamoxifen and its metabolites on the rat perfused hindquarter vascular bed, Basic Clin. Pharmacol. Toxicol., 104, 400, 10.1111/j.1742-7843.2009.00377.x Silva, 2011, Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers, Eur. J. Clin. Pharmacol., 67, 365, 10.1007/s00228-011-1003-x Guimarães, 2013, Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension, Redox Biol., 1, 578, 10.1016/j.redox.2013.11.004 Ceron, 2013, Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-beta and MMPs, and decreases vascular remodeling in renovascular hypertension, Free Radic. Biol. Med., 65, 47, 10.1016/j.freeradbiomed.2013.06.033 Classen, 1990, Hypothesis: the effect of oral nitrite on blood pressure in the spontaneously hypertensive rat. Does dietary nitrate mitigate hypertension after conversion to nitrite?, J. Am. Coll. Nutr., 9, 500, 10.1080/07315724.1990.10720407 Tsuchiya, 2005, Nitrite is an alternative source of NO in vivo, Am. J. Physiol. Heart Circ. Physiol., 288, H2163, 10.1152/ajpheart.00525.2004 Ceron, 2012, Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension, Matrix Biol., 31, 261, 10.1016/j.matbio.2012.01.009 Martins-Oliveira, 2013, Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling, Int. J. Cardiol., 167, 1199, 10.1016/j.ijcard.2012.03.137 Castro, 2009, Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension, Free Radic. Biol. Med., 46, 1298, 10.1016/j.freeradbiomed.2009.02.011 Dias-Junior, 2009, Nitrite or sildenafil, but not BAY 41–2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress, Thromb. Res., 124, 349, 10.1016/j.thromres.2008.12.006 Ceron, 2010, Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension, Br. J. Pharmacol., 160, 77, 10.1111/j.1476-5381.2010.00678.x Marçal, 2011, Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension, Naunyn Schmiedebergs Arch. Pharmacol., 383, 35, 10.1007/s00210-010-0573-y Castro, 2013, Inhibition of matrix metalloproteinases (MMPs) as a potential strategy to ameliorate hypertension-induced cardiovascular alterations, Curr. Drug Targets., 14, 335